P2.12-21 Outcomes with Immune Checkpoint Inhibitors (ICI) for Relapsed Small Cell Lung Cancer (SCLC) in a Swiss Cohort

Authors :: Alfredo Addeo
S. Schaer
Alex Friedlaender
Patrizia Froesch
Christian Britschgi
L.A. Mauti
Luciano Wannesson
Sabine Schmid
I. Demmer
Wolfram Jochum
Sacha I. Rothschild
Martin Früh
Veronika Blum
Wolf-Dieter Janthur
H. Bouchaab
D. Koenig
Source :: Journal of Thoracic Oncology. 14:S821-S822
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
Internal medicine
Immune checkpoint inhibitors
Cohort
medicine
business
Relapsed Small Cell Lung Cancer

Tools